Better tobacco treatment for people living with HIV
Optimizing Tobacco Treatment Delivery for People Living with HIV
This project tries different, easier ways to offer smoking help to people living with HIV so more can quit.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11286853 on NIH RePORTER |
What this research studies
You would be offered proven quitting tools—medications and counseling—through your HIV clinic while researchers compare a proactive, opt-out way of offering treatment to the usual approach. They will measure who accepts treatment, who stays engaged, and whether people stop smoking over time. The team aims to change how clinics reach smokers with HIV so more patients get help. If the opt-out approach works, it could become part of routine HIV care.
Who could benefit from this research
Good fit: Adults living with HIV who currently smoke and receive care at participating HIV clinics are the ideal candidates for this program.
Not a fit: People who do not smoke, who have already quit, or who do not attend the participating clinics are unlikely to benefit directly from this work.
Why it matters
Potential benefit: If successful, more people living with HIV could start and complete tobacco treatment and lower their risk of smoking-related illnesses like lung cancer.
How similar studies have performed: Prior studies in general medical populations show that proactive, opt-out tobacco treatment increases reach and quit rates, but this strategy has not been fully tested in people living with HIV.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Rojewski, Alana — Medical University of South Carolina
- Study coordinator: Rojewski, Alana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.